The Addition of Evacetrapib to Atorvastatin Compared to Placebo, High Intensity Atorvastatin, and Atorvastatin With Ezetimibe to Evaluate LDL-C Lowering in Patients With Primary Hyperlipidemia - The ACCENTUATE Study
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Evacetrapib (Primary) ; Atorvastatin; Ezetimibe
- Indications Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- Acronyms ACCENTUATE
- Sponsors Eli Lilly
- 02 Sep 2016 Status changed from completed to discontinued due to program termination.
- 30 Aug 2016 Status changed from discontinued to completed.
- 10 Dec 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.